Koklu Esad, Taskale Tuncay, Koklu Selmin, Ariguloglu Erdal Avni
Division of Neonatology, Megapark Hospital , Kahramanmaraş , Turkey .
J Matern Fetal Neonatal Med. 2014 Jul;27(11):1180-1. doi: 10.3109/14767058.2013.847425. Epub 2013 Oct 17.
Newborn infants are born with an immature innate immunity. They are less likely to develop anaphylaxis since their immune system is weaker than older infants and children. There are only a few reports of side effects after vitamin K injection in neonates although prophylaxis against hemorrhagic disease of the newborn with this drug has been in routine practice in all over the world for many years. We herein report a case of anaphylactic shock developing after the intramuscular administration of vitamin K1 in a newborn. To our knowledge, this patient is the first case of neonatal anaphylactic shock developing due to intramuscular administration of vitamin K1. We suggest the clinicians should be aware of this possibility of potentially fatal adverse effect occurring with intramuscular administration of vitamin K1.
新生儿出生时先天免疫不成熟。由于其免疫系统比大龄婴儿和儿童弱,他们发生过敏反应的可能性较小。尽管多年来在全球范围内使用这种药物预防新生儿出血性疾病已成为常规做法,但关于新生儿维生素K注射后副作用的报道却很少。我们在此报告一例新生儿肌肉注射维生素K1后发生过敏性休克的病例。据我们所知,该患者是首例因肌肉注射维生素K1而发生新生儿过敏性休克的病例。我们建议临床医生应意识到肌肉注射维生素K1可能会出现这种潜在致命不良反应的可能性。